In this Issue:
ART and cerebral small vessel disease
Virologic failure and HIV drug resistance during LLV
HIV life expectancy during ART
Meta-analysis of pill burden and once- vs twice-daily ART
HIV-1 suppression with incomplete CD4 recovery: mortality risk
Prenatal exposure to ART and birth defects
Raltegravir for HIV and tuberculosis coinfection
Estimation of per-act HIV transmission risk: systematic review
Early vs delayed initiation of ART
Please login below to download this issue (PDF)